Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa

Yanyan Hu1, Yan Qing1, Jiawei Chen1

  • 1Clinical Microbiology Laboratory, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Zhejiang University, Hangzhou, China.

Microbiology Spectrum
|November 24, 2021
PubMed

Insights

The human gut harbors carbapenem-resistant Pseudomonas aeruginosa (CRPA), a multidrug-resistant pathogen. Key risk factors for intestinal CRPA include prior antibiotic use, diabetes, and other P. aeruginosa infections.

Area of Science:

  • Clinical microbiology
  • Infectious diseases
  • Molecular epidemiology

Background:

  • The human gastrointestinal tract serves as a reservoir for Pseudomonas aeruginosa and its resistance genes.
  • Pseudomonas aeruginosa can develop multidrug resistance (MDR) through various genetic mechanisms.
  • Carbapenem-resistant P. aeruginosa (CRPA) poses a significant threat in healthcare settings.

Purpose of the Study:

  • To investigate the prevalence and molecular characteristics of intestinal CRPA strains.
  • To identify clinical risk factors associated with CRPA colonization in hospitalized patients.
  • To understand the genetic elements contributing to carbapenem resistance in P. aeruginosa.

Main Methods:

  • Collection and analysis of 76 intestinal CRPA strains from clinical inpatients (2014-2019).
  • Statistical analysis to identify risk factors for intestinal CRPA positivity.
  • Molecular methods to detect carbapenemase genes and characterize CRPA isolates (e.g., sequencing types).

Main Results:

  • CRPA prevalence among P. aeruginosa strains was 41.3%.
  • Four risk factors for intestinal CRPA were identified: prior aminoglycoside or carbapenem exposure, diabetes mellitus, and extraintestinal P. aeruginosa isolation.
  • The blaKPC-2 gene was the sole carbapenemase detected (21.1% of CRPA), often associated with mobile genetic elements like ISKpn8 and ISKpn6.
  • ST463 was the dominant sequence type among the CRPA isolates.

Conclusions:

  • Screening for P. aeruginosa colonization on hospital admission can help mitigate CRPA infection and spread.
  • Understanding risk factors and molecular epidemiology is crucial for controlling CRPA dissemination.
  • The findings highlight the importance of monitoring intestinal reservoirs for antibiotic-resistant bacteria in hospitals.

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
132
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.8K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
341
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
388
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
9.1K